Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muriel Cornet

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 17, 2025
Humanized Candida and NanoBiT Assays Expedite Discovery of Bdf1 Bromodomain Inhibitors With Antifungal PotentialKaiyao Wei, Marie Arlotto, Justin M Overhulse, et al.
Annals of Intensive Care|June 10, 2020
Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancyJohanna Claustre, Romaric Larcher, Thomas Jouve, et al.
Tropical Medicine and Infectious Disease|September 27, 2019
The Diagnosis of Fungal Neglected Tropical Diseases (Fungal NTDs) and the Role of Investigation and Laboratory Tests: An Expert Consensus ReportRoderick Hay, David W Denning, Alexandro Bonifaz, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2016
Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilationVincent Jullien, Elie Azoulay, Carole Schwebel, et al.
JAMA|October 6, 2016
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical TrialJean-Francois Timsit, Elie Azoulay, Carole Schwebel, et al.
Plos Neglected Tropical Diseases|October 15, 2024
A global chromoblastomycosis strategy and development of the global chromoblastomycosis working groupDallas J Smith, Flávio Queiroz-Telles, Fahafahantsoa Rapelanoro Rabenja, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 24, 2018
Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study "MFIP"Laurence Delhaes, Kada Touati, Odile Faure-Cognet, et al.
Journal De Mycologie Medicale|November 22, 2024
Laboratory practices for the diagnosis and management of mucormycosis in France, 2024Laurence Millon, Françoise Botterel, Julie Bonhomme, et al.
Emerging Infectious Diseases|July 18, 2018
Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained SettingsDavid W Denning, Iain D Page, Jeremiah Chakaya, et al.
Open Forum Infectious Diseases|February 12, 2024
<i>Cryptococcus neoformans</i> Infections Differ Among Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Individuals: Results From a Nationwide Surveillance Program in FranceOlivier Paccoud, Marie Desnos-Ollivier, Sophie Cassaing, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 17, 2025
Humanized Candida and NanoBiT Assays Expedite Discovery of Bdf1 Bromodomain Inhibitors With Antifungal PotentialKaiyao Wei, Marie Arlotto, Justin M Overhulse, et al.
Annals of Intensive Care|June 10, 2020
Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancyJohanna Claustre, Romaric Larcher, Thomas Jouve, et al.
Tropical Medicine and Infectious Disease|September 27, 2019
The Diagnosis of Fungal Neglected Tropical Diseases (Fungal NTDs) and the Role of Investigation and Laboratory Tests: An Expert Consensus ReportRoderick Hay, David W Denning, Alexandro Bonifaz, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2016
Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilationVincent Jullien, Elie Azoulay, Carole Schwebel, et al.
JAMA|October 6, 2016
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical TrialJean-Francois Timsit, Elie Azoulay, Carole Schwebel, et al.
Plos Neglected Tropical Diseases|October 15, 2024
A global chromoblastomycosis strategy and development of the global chromoblastomycosis working groupDallas J Smith, Flávio Queiroz-Telles, Fahafahantsoa Rapelanoro Rabenja, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 24, 2018
Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study "MFIP"Laurence Delhaes, Kada Touati, Odile Faure-Cognet, et al.
Journal De Mycologie Medicale|November 22, 2024
Laboratory practices for the diagnosis and management of mucormycosis in France, 2024Laurence Millon, Françoise Botterel, Julie Bonhomme, et al.
Emerging Infectious Diseases|July 18, 2018
Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained SettingsDavid W Denning, Iain D Page, Jeremiah Chakaya, et al.
Open Forum Infectious Diseases|February 12, 2024
<i>Cryptococcus neoformans</i> Infections Differ Among Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Individuals: Results From a Nationwide Surveillance Program in FranceOlivier Paccoud, Marie Desnos-Ollivier, Sophie Cassaing, et al.
Pageof 9